Mary K. Moreland, executive vice president of Abbott Laboratories ($ABT), made one open market sale of company shares in the last year, totaling $70,851. Her most recent sale occurred on March 2, 2026. This activity ranks her 10,014th among 11,678 insiders with sales, well below the average of $8.6 million per seller and 6.4 transactions. She recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 613 | $115.58 | 116,136.0000 | 1,996,795,525 | 0.53% | 0.00% |
| Feb. 27, 2026 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 4630 | $116.26 | 116,749.0000 | 1,996,795,525 | 3.81% | 0.00% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 57512 | $0.00 | 57,512.0000 | 1,996,795,525 | 9999.99% | 0.00% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 13951 | $0.00 | 121,379.0000 | 1,996,795,525 | 12.99% | 0.00% |
| Feb. 28, 2025 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 5598 | $135.87 | 107,997.0000 | 1,991,472,630 | 4.93% | 0.00% |
| March 3, 2025 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 791 | $138.17 | 107,206.0000 | 1,991,472,630 | 0.73% | 0.00% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 10712 | $0.00 | 113,595.0000 | 1,991,472,630 | 10.41% | 0.00% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 39896 | $0.00 | 39,896.0000 | 1,991,472,630 | 9999.99% | 0.00% |
| Feb. 29, 2024 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 5862 | $120.05 | 103,335.0000 | 1,987,883,852 | 5.37% | 0.00% |
| March 1, 2024 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 676 | $118.50 | 102,659.0000 | 1,987,883,852 | 0.65% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 10574 | $0.00 | 109,197.0000 | 1,987,883,852 | 10.72% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 39734 | $0.00 | 39,734.0000 | 1,987,883,852 | 9999.99% | 0.00% |
| March 1, 2023 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 717 | $100.77 | 98,404.0000 | 1,986,519,278 | 0.72% | 0.00% |
| Feb. 28, 2023 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 5926 | $99.77 | 99,121.0000 | 1,986,519,278 | 5.64% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 48344 | $0.00 | 48,344.0000 | 1,986,519,278 | 9999.99% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Moreland Mary K | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 12259 | $0.00 | 105,047.0000 | 1,986,519,278 | 13.21% | 0.00% |